| ID | Name | CAS | Properties |
logPoct/wat |
| 66-146-7 |
3-Buten-2-one, 4-(2,2-dimethyl-6-methylenecyclohexyl)-
|
79-76-5 |
6 | 3.514 |
| 66-216-9 |
Glutaric acid, 2-(4-bromophenyl)ethyl 2-methylhex-3-yl ester
|
|
6 | 5.073 |
| 66-304-1 |
exo-Bicyclo[2.2.1]hept-5-en-2-carboxylic acid, 7,7-cyclopropano-2-methyl, methyl ester
|
|
6 | 2.152 |
| 66-337-5 |
1,5,5-trimethyl-9-oxabicyclo[4.3]non-6-en-3-one
|
|
6 | 2.091 |
| 66-383-4 |
D-Alanine, N-(2,4,5-trifluoro-3-methoxybenzoyl)-, ethyl ester
|
|
6 | 1.794 |
| 66-606-6 |
Tricyclo[4.3.2.0(1,6)undeca-3-ene
|
136630-09-6 |
6 | 3.287 |
| 66-652-5 |
2,3-Di-O-acetyl-1,5-Anhydro-4,6-di-O-methyl-D-mannitol
|
|
6 | -0.090 |
| 66-702-9 |
2,2,2-Trifluoro-N-bis[2-[(2,2,2-trifluoroacetyl)amino]phenyl]acetamide
|
|
6 | 3.172 |
| 66-961-2 |
3,5-Cyclohexadiene-1,2-dione, 3,4,5,6-tetrachloro-
|
|
6 | 2.517 |
| 67-019-7 |
(1S,5S)-2-Methyl-5-((R)-6-methylhept-5-en-2-yl)bicyclo[3.1.0]hex-2-ene
|
159407-35-9 |
6 | 4.725 |
| 67-041-2 |
1-(1-Butoxypropan-2-yloxy)propan-2-yl 3,5,5-trimethylhexanoate
|
|
6 | 4.602 |
| 67-055-7 |
1(3H)-Isobenzofuranone, 3,3-bis(3,5-dibromo-4-hydroxyphenyl)-
|
76-62-0 |
6 | 6.610 |
| 67-088-1 |
Bisabola-1(6),10-dien-cis-2,3-diol A
|
|
6 | 3.057 |
| 67-112-3 |
3,3-Dimethylbicylo[3.2.0]hepta-1,4-diene
|
|
6 | 2.673 |
| 67-146-6 |
D-2,3-Diaminopropionic acid, N-ethoxycarbonyl, (S)-1-phenylethylamide
|
|
6 | 1.725 |
| 67-188-0 |
Estr-4-en-3-one, 17«alpha»-hydroxy-17-methyl-
|
10582-09-9 |
6 | 3.879 |
| 67-289-8 |
Cyclohexanemethanol, 4-ethenyl-«alpha»,«alpha»,4-trimethyl-3-(1-methylethenyl)-, [1R-(1«alpha»,3«alpha»,4«beta»)]-
|
639-99-6 |
6 | 3.942 |
| 67-438-2 |
1,2,4,6-Tetrathiepane, 3,5,7-trimethyl, #1
|
|
6 | 3.886 |
| 67-442-7 |
Naphthalene, decahydro-1,1,4a-trimethyl-6-methylene-5-(3-methylene-4-pentenyl)-, [4aS-(4a«alpha»,5«alpha»,8a«beta»)]-
|
511-02-4 |
6 | 6.308 |
| 67-511-0 |
Androstane-11,17-dione, 3-hydroxy-, (3«alpha»,5«beta»)-
|
739-27-5 |
6 | 3.138 |
| 67-624-5 |
3-epi-3,6;6,9-Bisepoxyfarnesa-1,7(14),10-triene
|
|
6 | 3.749 |
| 67-713-6 |
2-Butanone, 4-(2,6,6-trimethyl-2-cyclohexen-1-yl)-
|
31499-72-6 |
6 | 3.738 |
| 67-881-0 |
o-Anisic acid, 2,6-dimethylnon-1-en-3-yn-5-yl ester
|
|
6 | 4.236 |
| 67-920-6 |
3H-Pyrazol-3-one, 2,4-dihydro-5-methyl-2-phenyl-
|
89-25-8 |
6 | 1.799 |
| 67-939-6 |
Bicyclo[2.2.1]heptan-2-ol, 2,7,7-trimethyl, endo
|
|
6 | 2.194 |
| 67-947-7 |
10,11-epi-10,11-epoxy-ar-curcumen-15-al
|
|
6 | 3.560 |
| 68-030-3 |
5-Hydroxy-2-(4-hydroxyphenyl)-4-oxo-3,4-dihydro-2h-chromen-7-yl 6-o-(6-deoxyhexopyranosyl)hexopyranoside
|
|
6 | -1.165 |
| 68-037-6 |
Succinic acid, 3,5-dimethylphenyl N,N-diethyl-2-aminoethyl ester
|
|
6 | 2.874 |
| 68-062-8 |
6,7-Diazatricyclo[3.2.2.0(2,4)]non-6-ene, oxide
|
25926-99-2 |
6 | 1.130 |
| 68-097-0 |
Bicyclo[3.1.0]hexan-2-ol, 2-methyl-5-(1-methylethyl)-, (1«alpha»,2«alpha»,5«alpha»)-
|
17699-16-0 |
6 | 2.194 |
| 68-189-8 |
m-Toluic acid, 2,6-dimethylnon-1-en-3-yn-5-yl ester
|
|
6 | 4.536 |
| 68-231-0 |
8-(4-Methylpentene-3-yl) spiro[4.5]decene-7-one-1
|
|
6 | 4.583 |
| 68-276-1 |
trans-Phenanthrene, 9,10-dihydro-9,10-diol, bis-TMS
|
|
6 | 6.152 |
| 68-288-8 |
7-Difluoromethoxy-2,3-dihydro-5-phenyl-1H-1,4-benzodiazepin-2-one
|
55384-53-7 |
6 | 3.077 |
| 68-349-0 |
4-ethyl-2,5-dimethoxy-«beta»-phenethylamine-M, (O-desmethyl-desamino-COOH), isomer 2, methyl-acetylated
|
|
6 | 1.898 |
| 68-506-5 |
5-(4-Methoxyphenyl)-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-ol
|
|
6 | 4.078 |
| 68-512-8 |
trans-3-Trifluoromethylcinnamic acid, 2,6-dimethylnon-1-en-3-yn-5-yl ester
|
|
6 | 5.646 |
| 68-844-0 |
Androst-5-ene-17,17-ethylenedioxy-3b-hydroxy-,p-nitrobenzoate
|
125567-35-3 |
6 | 5.826 |
| 69-022-1 |
17-(1,5-Dimethyl-hex-2-enyl)-10,13-dimethyl-2,3,4,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol
|
|
6 | 7.085 |
| 69-025-8 |
exo-Bicyclo[2.2.1]heptan-2-carboxylic acid, 2,7,7-trimethyl, methyl ester
|
|
6 | 2.622 |
| 69-085-2 |
7,14-Methano-2H,6H-dipyrido[1,2-a:1',2'-e][1,5]diazocine, dodecahydro-, [7S-(7«alpha»,7a«beta»,14«alpha»,14a«beta»)]-
|
24915-04-6 |
6 | 2.345 |
| 69-130-1 |
3,7-Bis[(trimethylsilyl)oxy]cholest-5-ene, (3«beta»,7«beta»)-
|
33287-26-2 |
6 | 10.078 |
| 69-145-5 |
Tricyclo[5.2.1.0(2.6)]deca-3,8-diene, 4.9-dimethyl
|
|
6 | 3.165 |
| 69-159-0 |
3-Amino-2,5-dichlorobenzoic acid, N-dimethylaminomethylene-, ethyl ester
|
|
6 | 3.391 |
| 69-190-5 |
Oxybis(ethane-2,1-diyl) bis(2,3,4,5,6-pentafluorobenzoate)
|
|
6 | 4.108 |
| 69-265-2 |
D-Aspartic acid, N-methyl, N-ethoxycarbonyl, (S)-1-phenylethylamide
|
|
6 | 3.588 |
| 69-488-5 |
3-Buten-2-one, 4-(4-hydroxy-2,2,6-trimethyl-7-oxabicyclo[4.1.0]hept-1-yl)-
|
38274-01-0 |
6 | 1.840 |
| 69-626-1 |
Naphthalene, 1,2,3,4,4a,5,6,8a-octahydro-4a,8-dimethyl-2-(1-methylethenyl)-, [2R-(2«alpha»,4a«alpha»,8a«beta»)]-
|
473-13-2 |
6 | 4.725 |
| 69-670-2 |
(3S,3aR,3bR,4S,7R,7aR)-4-Isopropyl-3,7-dimethyloctahydro-1H-cyclopenta[1,3]cyclopropa[1,2]benzen-3-ol
|
23445-02-5 |
6 | 3.466 |
| 69-761-1 |
2H-Pyran-3-ol, 6-ethenyltetrahydro-2,2,6-trimethyl-
|
14049-11-7 |
6 | 1.881 |
| 69-763-9 |
(3R,6R)-2,2,6-Trimethyl-6-vinyltetrahydro-2H-pyran-3-ol
|
14009-71-3 |
6 | 1.881 |
| 69-822-3 |
5«alpha»-Androstane-3«beta»,17«beta»-diol, bis(trifluoroacetate)
|
|
6 | 5.977 |
| 69-867-4 |
2-Buten-1-one, 1-(2,6,6-trimethyl-1,3-cyclohexadien-1-yl)-
|
23696-85-7 |
6 | 3.434 |
| 69-919-6 |
Tricyclo[4.3.1.0(1,6)deca-3-ene
|
17048-59-8 |
6 | 2.897 |
| 69-928-6 |
Cyclopentane, 1,2,3,4,5-pentamethyl-, (1,2,3/4,5)-
|
33067-32-2 |
6 | 3.180 |
| 70-036-4 |
Silane, [[(3«beta»,5«beta»)-cholestan-3-yl]oxy]trimethyl-
|
55331-94-7 |
6 | 9.328 |
| 70-154-3 |
3-epi-6,9-Epoxyfarnesa-1,7(14),10-trien-3-ol
|
|
6 | 3.383 |
| 70-233-5 |
6,9-Epoxyfarnesa-1,7(14),10-trien-3-ol
|
|
6 | 3.383 |
| 70-300-0 |
2-Oxabicyclo[2.2.2]octan-6-ol, 1,3,3-trimethyl-, acetate
|
57709-95-2 |
6 | 2.286 |
| 70-341-5 |
1,2,4,6-Tetrathiepane, 3,5,7-trimethyl, #2
|
|
6 | 3.886 |
| 70-353-2 |
1,2,4,6-Tetrathiepane, 3,5,7-trimethyl, #3
|
|
6 | 3.886 |
| 70-423-4 |
Cyclohexene, 3-(1,5-dimethyl-4-hexenyl)-6-methylene-, [S-(R*,S*)]-
|
20307-83-9 |
6 | 4.891 |
| 70-511-6 |
1,3,5-Dithiazine, perhydro, 2,4,6-trimethyl, #3
|
|
6 | 2.094 |
| 70-521-5 |
1,3,5-Dithiazine, perhydro, 2,4,6-trimethyl, #1
|
|
6 | 2.094 |
| 70-532-3 |
9-Hydroxymegastigma-4,6-dien-3-one (isomer # 1)
|
|
6 | 2.629 |
| 70-544-0 |
Naphthalene, 1,2,3,4,4a,5,6,7-octahydro-8-methoxy-
|
101555-42-4 |
6 | 3.261 |
| 70-560-2 |
3,6;6,9-Bisepoxyfarnesa-1,7(14),10-triene
|
|
6 | 3.749 |
| 70-587-3 |
Cyclohexane, 1-ethenyl-1-methyl-2-(1-methylethenyl)-4-(1-methylethylidene)-
|
3242-08-8 |
6 | 4.891 |
| 70-635-9 |
Bicyclo[3.1.0]hexan-2-ol, 2-methyl-5-(1-methylethyl)-, (1«alpha»,2«beta»,5«alpha»)-
|
15537-55-0 |
6 | 2.194 |
| 70-636-8 |
Bicyclo[3.1.0]hexan-2-ol, 2-methyl-5-(1-methylethyl)-
|
546-79-2 |
6 | 2.194 |
| 70-644-9 |
9-Hydroxymegastigma-4,6-dien-3-one (isomer # 2)
|
|
6 | 2.629 |
| 70-716-9 |
4,5,7,8-Tetrathia-(E)-2-undecene, 6-ethyl
|
|
6 | 5.429 |
| 70-726-8 |
Cyclopropanecarboxylic acid, 3-(2,2-dichlorovinyl)-2,2-dimethyl-, (3-phenoxyphenyl)methyl ester, (1R-cis)-
|
54774-45-7 |
6 | 6.113 |
| 70-752-9 |
3,9-diepi-3,6,6,9-Bisepoxy-farnesa-1,7(14),10-triene
|
|
6 | 3.749 |
| 70-753-8 |
9-epi-3,6,6,9-Bisepoxy-farnesa-1,7(14),10-triene
|
|
6 | 3.749 |
| 70-758-3 |
Cyclopropanecarboxylic acid, 3-(2,2-dichloroethenyl)-2,2-dimethyl-, (3-phenoxyphenyl)methyl ester, trans-
|
61949-77-7 |
6 | 6.113 |
| 70-801-4 |
2-Cyclohexen-1-one, 4-(3-hydroxy-1-butenyl)-3,5,5-trimethyl-
|
34318-21-3 |
6 | 2.485 |
| 70-827-6 |
24-Methyl-5-«alpha»-cholesta-7,22-dien-3-«beta»-ol
|
|
6 | 7.411 |
| 70-978-9 |
(E,E)-1,3,5-Tridecatriene-7,9,11-triyne
|
|
6 | 2.315 |
| 71-077-8 |
2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2,2,3,3,4,4,4-Heptafluorobutanoyl)oxyethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethyl 2,2,3,3,4,4,4-heptafluorobutanoate
|
|
6 | 3.954 |
| 71-094-9 |
Lanost-9(11)-en-3-ol, acetate, (3«beta»,8«alpha»,13«alpha»,14«beta»,17«alpha»)-
|
55515-26-9 |
6 | 8.986 |
| 71-099-4 |
1,4-Dimethyl-7-(prop-1-en-2-yl)decahydroazulen-4-ol
|
21698-41-9 |
6 | 3.776 |
| 71-128-1 |
4,7,7-Trimethylbicyclo[3.2.0]hept-3-en-6-one
|
4613-37-0 |
6 | 2.178 |
| 71-165-0 |
(1S,4S,4aS)-1-Isopropyl-4,7-dimethyl-1,2,3,4,4a,5-hexahydronaphthalene
|
267665-20-3 |
6 | 4.581 |
| 71-186-7 |
(1R,3S,4S)-1,3-Dimethyl-3-(4-methylpent-3-en-1-yl)-2-oxabicyclo[2.2.2]oct-5-ene
|
211237-38-6 |
6 | 4.247 |
| 71-199-3 |
1,3,5-Dithiazine, perhydro, 2,4,6-trimethyl, #2
|
|
6 | 2.094 |
| 71-352-2 |
1-Isopropyl-4,7-dimethyl-1,2,3,4,5,6-hexahydronaphthalene
|
16729-00-3 |
6 | 4.725 |
| 71-358-6 |
(2E,4S,7E)-4-Isopropyl-1,7-dimethylcyclodeca-2,7-dienol
|
198991-79-6 |
6 | 4.086 |
| 71-361-2 |
1H-3«alpha»,7-Methanoazulene,2,3,4,7,8,8«alpha»-hexahydro-3,6,8,8-tetramethyl
|
|
6 | 4.415 |
| 71-438-7 |
(3S,3aS,6R,8aS)-3,8,8-Trimethyl-7-methyleneoctahydro-1H-3a,6-methanoazulene
|
31145-21-8 |
6 | 4.415 |
| 71-530-4 |
2,3,6-Tri-O-acetyl-1,5-anhydro-4-O-methyl-D-glucitol
|
|
6 | -0.173 |
| 71-579-1 |
6-Ethyl-4,5,7,8-tetrathia-cis-2-undecene
|
126876-36-6 |
6 | 5.429 |
| 71-621-3 |
3,4-Di-O-acetyl-1,5-anhydro-2,6-di-O-methyl-D-glucitol
|
|
6 | -0.090 |
| 71-669-1 |
1aR-1a«alpha»,4a«alpha»,7«alpha»,7a«beta»,7b«alpha»-Decahydro-1,1,7-trimethyl-4-methylene-1H-cycloprop[e]azulene
|
|
6 | 4.271 |
| 71-710-4 |
2,6-Di-O-acetyl-1,5-Anhydro-3,4-di-O-methyl-D-mannitol
|
|
6 | -0.090 |
| 71-770-8 |
4a,8-Dimethyl-2-(prop-1-en-2-yl)-1,2,3,4,4a,5,6,7-octahydronaphthalene
|
103827-22-1 |
6 | 4.869 |
| 71-805-9 |
(S,Z)-2-Methyl-6-(p-tolyl)hept-2-en-1-ol
|
78339-53-4 |
6 | 3.817 |
| 71-816-7 |
Bicyclo(3.1.1)heptane-2,3-diol, 2,6,6-trimethyl-
|
53404-49-2 |
6 | 1.164 |
| 71-912-0 |
3,6-Di-O-acetyl-1,5-anhydro-2,4-di-O-methyl-D-mannitol
|
|
6 | -0.090 |
| 71-931-9 |
2(3H)-Naphthalenone, 4,4a,5,6,7,8-hexahydro-4a,5-dimethyl-3-(1-methylethylidene)-, (4ar-cis)-
|
19598-45-9 |
6 | 4.048 |
|
« Previous Results
Next Results »
|